H
Hyperfine
Portable, ultra-low field MR brain imaging system enabling timely clinical decisions at the point of care
About Hyperfine
Hyperfine, Inc. is a pioneering health technology company that has developed the Swoop system, the first FDA-cleared, portable, ultra-low field magnetic resonance imaging (MRI) system. The Swoop system is designed to bring MR brain imaging directly to the patient's bedside, particularly in intensive care units, thereby eliminating the need to transport critically ill patients to radiology departments. This innovation allows for timelier treatment decisions, quicker patient discharges, and more efficient use of hospital staff and resources. The system's open and safe design also enables family members to stay close and provide comfort during imaging procedures. Hyperfine's primary clients include hospitals, clinics, and other healthcare facilities that require accessible and efficient diagnostic imaging solutions. The company operates in the global healthcare market, focusing on improving patient care through advanced imaging technology. Hyperfine generates revenue by selling its Swoop system and related services to healthcare providers. The business model is centered around providing a cost-effective, portable MRI solution that enhances clinical decision-making and patient outcomes.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2014
- Headquarters
- Guilford, United States
- Employees
- 121
- Open positions
- None listed
- Dealroom signal
- 68.4/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Neurology, Radiology, Medical Imaging, SPAC Target, SPAC IPO Announced, Hard Tech, DT and LS, science-based
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
Latest news
Press, funding announcements and product moves mentioning Hyperfine.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| POST IPO DEBTDebt | Mar 2026 | $0 | — | Horizon Technology Finance Corporation | ↗ |
| GRANTOther financing | Nov 2025 | $3.7M | — | Bill & Melinda Gates Foundation | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Hyperfine is 10K monthly website visits, up 185.7% over the last three months. Hyperfine's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
Bill & Melinda Gates Foundation
Series B and later15 investors entered at this stage
Altium Capital
Colle Capital Partners
Huami Technology- AAAxiom Associates
Lss Capital Markets
Nextrans Korea
Bain Capital
Deerfield
Avidity Partners
HealthCor Management
Perceptive Advisors
Eldridge
Catalio Capital Management- HCHealthCor Catalio Acquisition Corp
Horizon Technology Finance Corporation
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Hyperfine on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Hyperfine’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.